Resource utilization for multidrug-resistant tuberculosis household contact investigations (A5300/I2003)

Swindells, Susan; Gupta, Amita; Kim, Soyeon; Hughes, Michael D.; Sanchez, Jorge; Mave, Vidya; Dawson, Rodney; Kumarasamy, Nagalingeswaran; Comins, Kyla; Smith, Betsy; Rustomjee, Roxana; Naini, Linda; Shah, N. Sarita; Hesseling, Anneke; Churchyard, Gavin; ACTG5300/IMPAACT2003 PHOENIx Feasibility Study Team.
Artículo en Inglés | ARCA | ID: arc-37892

Documentos relacionados

  1. Peritonitis tuberculosa: revisión de 16 años en un hospital general
  2. The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study.
  3. Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study.
  4. Management of drug-resistant tuberculosis.
  5. Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone.
  6. [Expert consensus on surgical treatment of multidrug-resistant and rifampicin-resistant pulmonary tuberculosis in China (2022 edition)].
  7. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates.
  8. Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis.
  9. Factors Associated With All-Cause Mortality Among Patients With Multidrug-Resistant Tuberculosis-United States, 1993-2013.
  10. Outcome of Candida auris contact investigations conducted in a 6 month period at a New York City hospital.